Concepedia

L-L. Miller

LM

Statistics

Publications

1

Citations

12

H-Index

1

Active since

2024

Affiliations

Multimeric Biotherapeutics (United States)(Current)

L-L. Miller is an author at Multimeric Biotherapeutics (United States) specializing in targeted therapy, targeted therapy pharmacology, and antibody-directed prodrugs.

Publications per year

2024–2024

1

Publications

1

721MO Phase I, two-part, multicenter first-in-human (FIH) study of TORL-1-23: A novel claudin 6 (CLDN6) targeting antibody drug conjugate (ADC) in patient with advanced solid tumors

G. Konecny, Andrea E. Wahner Hendrickson, Boris Winterhoff et al. · Annals of Oncology · 2024 · 12 citations · Full text

, , +17

1–1 of 1